AlveoliX develops organ-on-chip platforms that mimic human organs in vitro. It is part of a European consortium that has received a total of EUR 1 million in Eurostars funding to develop Nexopore, a technique for delivering nucleic acid therapies.
- Announced on
- Round
- Grant
- Amount
- Amount not disclosed
- Location
- Bern
- Sector
- Biotech & life sciences
Investors
- Eurostars lead
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic